Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine brachial plexus block in arthroscopic shoulder surgery
ChiCTR2300073946Phase 4Completed
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Apr 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoint: Incidence of postoperative rebound pain. Started Apr 2023; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300073946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073946.